The tobacco giant's reluctance to develop reduced risk materials could impact on long term growth after rival firms have poured billions into developing safer cigarette technology.
As more states legalize medical and recreational marijuana, the pot culture is spawning some big side industries.
New laboratory data reveal that vapour from a novel hybrid tobacco heating product (THP) iFuse and two standard THPs produced little or no effect on human cells in biological testing.
'Our results suggest that these standard THPs and our novel hybrid product have the potential to reduce smoking-related disease risks when compared with cigarette smoking,' says Dr James Murphy, Head of Reduced Risk Substantiation at British American Tobacco. 'However, further pre-clinical and clinical research is required to substantiate conclusive risk reduction of these products.'
'Our results suggest that these standard THPs and our novel hybrid product have the potential to reduce smoking-related disease risks when compared with cigarette smoking,' says Dr James Murphy, Head of Reduced Risk Substantiation at British American Tobacco. 'However, further pre-clinical and clinical research is required to substantiate conclusive risk reduction of these products.'
Reuters
